Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.

2.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

3.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

4.

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

5.

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot